Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00087555 · ClinicalTrials.gov registry record · Phase 2
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia
A Phase 2 study, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 195
- Enrollment target
NCT00087555 is a Phase 2 study that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 195 participants.
The verdict
NCT00087555, a Phase 2 study, has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 195 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Xyrem (sodium oxybate) is effective when used alone to treat the pain and sleep disturbances of fibromyalgia.
Interventions
- DRUG Placebo
- DRUG Xyrem (sodium oxybate) oral solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00087555
The ClinicalTrials.gov registry entry for NCT00087555 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00087555 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00087555 about?
NCT00087555 is a clinical study titled "Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia". The purpose of this study is to determine whether Xyrem (sodium oxybate) is effective when used alone to treat the pain and sleep disturbances of fibromyalgia.
What is the current status of trial NCT00087555?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 195 participants. The study started on 2004-07. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00087555?
The interventions under investigation include: Placebo (DRUG), Xyrem (sodium oxybate) oral solution (DRUG).
Who is sponsoring clinical trial NCT00087555?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.